SCHEMBL16446953

SCHEMBL16446953

CCc1nc(Cl)nc2c1ccn2C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ BUB1 O43683 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PIK3CD O00329 2/20 0.34
▸ ABL1 P00519 2/20 0.34
▸ EGFR P00533 2/20 0.34
▸ HCK P08631 2/20 0.34
▸ SRC P12931 2/20 0.34
▸ KDR P35968 2/20 0.34
▸ PIK3CA P42336 2/20 0.34
▸ PIK3CB P42338 2/20 0.34
▸ MTOR P42345 2/20 0.34
▸ PIK3CG P48736 2/20 0.34
▸ EPHB4 P54760 2/20 0.34
▸ PRKDC P78527 2/20 0.34
▸ PI4KB Q9UBF8 2/20 0.34
▸ AKT1 P31749 1/20 0.33
▸ GPR4 P46093 3/20 0.32
▸ BCHE P06276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16446631 0.84 HSP90AA1 (0.42) HSP90AA1HSP90AB1BUB1L3MBTL1PIK3CD
SCHEMBL31514802 0.83 HSP90AA1 (0.41) HSP90AA1HSP90AB1BUB1L3MBTL1PIK3CD
SCHEMBL16446729 0.83 HSP90AA1 (0.41) HSP90AA1HSP90AB1BUB1L3MBTL1PIK3CD
SCHEMBL31601053 0.75 HSP90AA1 (0.44) HSP90AA1HSP90AB1BUB1L3MBTL1PIK3CD
SCHEMBL29680739 0.75 HSP90AA1 (0.49) HSP90AA1HSP90AB1BUB1PIK3CDABL1
SCHEMBL24528657 0.75 HSP90AA1 (0.49) HSP90AA1HSP90AB1BUB1PIK3CDABL1
SCHEMBL17528555 0.75 HSP90AA1 (0.41) HSP90AA1HSP90AB1BUB1L3MBTL1PIK3CD
SCHEMBL23329532 0.74 HSP90AA1 (0.48) HSP90AA1HSP90AB1BUB1L3MBTL1PIK3CD
SCHEMBL16446529 0.74 PDE4B (0.47) L3MBTL1ALDH1A1
SCHEMBL17731738 0.74 ALOX5 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3030565-B1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS GRUENENTHAL GMBH (DE) 2017-07-19 — — EP disclosed
US-9688683-B2 Substituted condensed pyrimidine compounds Grünenthal GmbH (DE) 2017-06-27 — — US disclosed
EP-3030565-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-06-15 — — EP disclosed
US-20160152624-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-06-02 — — US disclosed
WO-2015018534-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2015-02-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152624-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS PDE4A, PDE4B, TYMP HSP90AA1 2636/4885HSP90AB1 2720/4885BUB1 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback